SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 26 | +1 |
| Shares | 1.69M | 11.7K | 2.98M | +1.30M (+77.5%) |
| Value | $11.3M | $78.0K | $6.64M | −$4.56M (−40.7%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Empery Asset Management, LP | 927,984 | $2.07M | 11.20% |
| Alyeska Investment Group, L.P. | 254,018 | $566.0K | 0.01% |
| Highbridge Capital Management LLC | 100,000 | $223.0K | 0.01% |
| Renaissance Technologies LLC | 33,838 | $75.0K | 0.00% |
| Two Sigma Investments, LP | 21,494 | $48.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 10,100 | $23.0K | 0.00% |
| JPMorgan Chase & Co | 3,550 | $8.00K | 0.00% |
| Parkside Financial Bank & Trust | 2 | $0 | 0.00% |
Sold out (7)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 101,554 | $678.0K |
| Ameriprise Financial Inc | 96,692 | $645.0K |
| Prelude Capital Management, LLC | 31,125 | $208.0K |
| D. E. Shaw & Co., Inc. | 22,086 | $148.0K |
| Dimensional Fund Advisors LP | 15,924 | $106.0K |
| Simplex Trading, LLC | 6,912 | $46.0K |
| Citigroup Inc | 1,918 | $13.0K |
Not filed for Q2 2022 yet (1)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 11,706 | $78.0K |